Xenon Pharmaceuticals Income Statement (2013-2026) | XENE

Income Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
41.41M51.63M53.06M62.24M62.54M62.59M63.11M63.72M65.00M75.37M75.46M75.67M75.79M76.42M76.59M76.94M77.12M80.01M96.62M96.84M
Revenue & cost
Revenue (Quarter)
8.12M3.74M8.77M0.54M0.13M7.50M
Operating items
Research & Development (Quarter)
18.89M21.89M19.36M22.15M29.43M-63.66M39.52M44.04M42.88M41.08M44.25M49.70M56.97M1.44M3.42M2.60M77.05M-200.72M4.20M99.22M
Selling, General & Administrative (Quarter)
4.83M6.69M6.78M8.71M8.83M8.50M9.54M11.58M12.80M12.62M14.79M19.40M16.71M18.00M19.04M19.24M19.28M22.07M23.82M23.93M
Restructuring Costs (Quarter)
4.90M5.66M4.56M5.54M5.53M6.01M6.71M8.53M7.80M8.03M
Other Operating Expenses (Quarter)
98.49M-4.90M-75.11M-78.79M-229.84M-27.60M-30.18M-6.71M-101.02M76.51M-8.03M
Operating Expenses (Quarter)
23.72M28.57M26.14M30.85M38.26M43.33M49.05M55.62M55.68M53.70M59.04M-0.34M-0.56M-204.85M0.39M-2.32M96.34M-271.13M112.33M123.16M
Operating Income (Quarter)
-15.60M-24.84M-17.37M-30.32M-38.13M-43.33M-49.05M-55.62M-55.68M-53.70M-59.04M-69.10M-73.68M-77.48M-72.74M-94.23M-96.34M-109.77M-112.33M-123.16M
EBIT (Quarter)
-15.60M-24.84M-17.37M-30.32M-38.13M-43.33M-49.05M-55.62M-55.68M-53.70M-59.04M-69.10M-73.68M-77.48M-72.74M-94.23M-96.34M-109.77M-112.33M-123.16M
Non-operating items
Non Operating Investment Income (Quarter)
-3.36M-1.29M
Interest & Investment Income (Quarter)
0.06M0.19M0.37M0.82M3.07M4.46M5.42M6.52M6.98M8.69M11.36M10.84M10.33M9.42M8.08M7.20M6.21M5.34M6.91M12.14M
Other Non Operating Income (Quarter)
-0.13M0.21M0.30M-0.41M-2.38M0.60M0.31M0.38M-0.41M-0.09M0.17M0.01M0.24M-1.48M0.04M1.70M-0.09M-0.30M0.55M-0.31M
Non Operating Income (Quarter)
-0.05M-0.24M-2.69M-0.88M0.39M7.08M7.61M7.94M7.07M8.75M11.52M10.85M10.57M7.94M8.12M8.90M6.12M5.04M7.46M11.83M
Net income details
EBT (Quarter)
-15.65M-25.08M-20.06M-31.20M-37.74M-36.26M-41.44M-47.68M-48.62M-44.95M-47.52M-58.26M-63.11M-69.53M-64.62M-85.33M-90.22M-110.89M-104.87M-111.32M
Tax Provisions (Quarter)
-0.20M2.52M-0.39M-0.04M-0.59M1.18M0.29M-0.22M-0.16M-0.20M0.41M-0.33M-0.32M-3.85M0.43M-0.63M0.68M3.74M-2.57M-0.58M
Profit After Tax (Quarter)
-15.45M-25.56M-19.67M-31.16M-39.12M-37.40M-41.73M-47.46M-48.12M-44.79M-47.93M-57.92M-62.79M-67.10M-65.05M-84.71M-90.90M-107.35M-102.30M-112.18M
Income from Non-Controlling Interests (Quarter)
-1.97M1.18M-1.48M0.35M-1.69M-0.44M3.55M0.78M0.95M0.36M-1.55M-1.45M
Income from Continuing Operations (Quarter)
-15.45M-27.60M-19.67M-31.16M-37.15M-37.44M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M-62.79M-65.69M-65.05M-84.71M-90.90M-114.63M-102.30M-110.74M
Consolidated Net Income (Quarter)
-15.45M-27.60M-19.67M-31.16M-37.15M-37.44M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M-62.79M-65.69M-65.05M-84.71M-90.90M-114.63M-102.30M-110.74M
Income towards Parent Company (Quarter)
-15.45M-27.60M-19.67M-31.16M-37.15M-37.44M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M-62.79M-65.69M-65.05M-84.71M-90.90M-114.63M-102.30M-110.74M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-15.08M-25.08M-19.37M-31.16M-37.15M-37.38M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M-62.79M-65.69M-65.05M-84.71M-90.90M-114.63M-102.30M-110.74M
Additional items
EPS (Basic) (Quarter)
-0.37-0.57-0.35-0.55-0.57-0.62-0.63-0.72-0.73-0.67-0.62-0.75-0.81-0.84-0.83-1.07-1.15-1.45-1.17-1.11
EPS (Diluted) (Quarter)
-0.36-0.57-0.35-0.55-0.57-0.62-0.63-0.72-0.73-0.67-0.62-0.75-0.81-0.84-0.83-1.07-1.15-1.45-1.17-1.11
Shares Outstanding (Quarter)
41.19M43.63M54.85M56.19M65.47M60.54M65.72M65.86M66.00M66.89M77.59M77.67M77.93M77.89M78.69M78.95M79.25M79.25M87.35M99.61M
Shares Outstanding (Diluted) (Quarter)
42.27M43.63M54.85M56.19M65.47M60.54M65.72M65.86M66.00M66.89M77.59M77.67M77.93M77.89M78.69M78.95M79.25M79.25M87.35M99.61M
EBITDA (Quarter)
-15.60M-24.84M-17.37M-30.32M-38.13M-43.33M-49.05M-55.62M-55.68M-53.70M-59.04M-69.10M-73.68M-77.48M-72.74M-94.23M-96.34M-109.77M-112.33M-123.16M
Interest Expenses (Quarter)
0.57M0.20M11.61M1.01M1.97M0.28M1.82M2.31M12.71M0.41M11.93M11.42M11.09M0.43M9.74M1.03M9.27M0.43M8.28M7.09M
Tax Rate (Quarter)
1.31-10.061.960.131.56-3.26-0.700.460.320.46-0.870.570.515.53-0.660.73-0.75-3.372.450.53